Director dealings: Accler8 chairman raises stake
Acceler8 Ventures
66.50p
17:21 20/10/26
Acceler8 Ventures revealed on Tuesday that chairman Nigel Rudd had acquired 121,429 ordinary shares in the London-listed life sciences business.
Nonequity Investment Instruments
0.00
17:17 25/09/06
Rudd, who joined Accler8 in August 2023, purchased the shares at an average price of 70p each, for a total price of £85,000.30.
Following the transaction, Rudd holds a beneficial interest in 10.64m ordinary Acceler8 shares, representing approximately 1.40% of the company's issued ordinary share capital.
As of 1530 BST, Acceler8 shares were up 4.84% at 65p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
The Character Group (CCT)
Director name: Shah,Kirankumar Premshand
Amount purchased: 67,611 @ 310.00p
Value: £209,594.09
Acceler8 Ventures (AC8)
Director name: Rudd,Nigel
Amount purchased: 121,429 @ 70.00p
Value: £85,000.30
Trekor Metals Limited Npv (di) (TKO)
Director name: Hallbauer,Russell
Amount purchased: 9,000 @ $11.16
Value: $59,421.40
Top Director Sells
The Character Group (CCT)
Director name: Shah,Kirankumar Premshand
Amount sold: 67,611 @ 310.00p
Value: £209,594.09